Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (21-30 of 400) with videos related to

Pageof 40
Sort By:
Contributions to Nephrology|April 9, 2008
Gene therapy for renal cancerYosef S Haviv, David T Curiel
Advances in Cancer Research|October 2, 2012
Chapter two--Adenovirus strategies for tissue-specific targetingMatthew S Beatty, David T Curiel
The Journal of General Virology|October 20, 2000
Blood clearance rates of adenovirus type 5 in miceRamon Alemany, Kaori Suzuki, David T Curiel
Human Gene Therapy|March 5, 2002
Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysisFrank A E Kruyt, David T Curiel
Plos One|February 8, 2014
Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypesJunji Uchino, David T Curiel, Hideyo Ugai
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2020
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editorsPaul Boucher, Xiaoxia Cui, David T Curiel
Expert Review of Anticancer Therapy|June 29, 2011
The potential of virus-based gene therapies for treatment of metastatic kidney cancerPaul Dent, David T Curiel, Paul B Fisher
Future Oncology (London, England)|March 25, 2006
Current developments in adenovirus-based cancer gene therapyDaniel T Rein, M Breidenbach, David T Curiel
ACS Synthetic Biology|January 10, 2023
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene TherapiesLogan Thrasher Collins, Selvarangan Ponnazhagan, David T Curiel
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Cancer gene therapy and immunotherapyYosuke Kawakami, Tyler J Curiel, David T Curiel
Pageof 40

Showing results (21-30 of 400) with videos related to

Sort By:
Pageof 40
Contributions to Nephrology|April 9, 2008
Gene therapy for renal cancerYosef S Haviv, David T Curiel
Advances in Cancer Research|October 2, 2012
Chapter two--Adenovirus strategies for tissue-specific targetingMatthew S Beatty, David T Curiel
The Journal of General Virology|October 20, 2000
Blood clearance rates of adenovirus type 5 in miceRamon Alemany, Kaori Suzuki, David T Curiel
Human Gene Therapy|March 5, 2002
Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysisFrank A E Kruyt, David T Curiel
Plos One|February 8, 2014
Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypesJunji Uchino, David T Curiel, Hideyo Ugai
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2020
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editorsPaul Boucher, Xiaoxia Cui, David T Curiel
Expert Review of Anticancer Therapy|June 29, 2011
The potential of virus-based gene therapies for treatment of metastatic kidney cancerPaul Dent, David T Curiel, Paul B Fisher
Future Oncology (London, England)|March 25, 2006
Current developments in adenovirus-based cancer gene therapyDaniel T Rein, M Breidenbach, David T Curiel
ACS Synthetic Biology|January 10, 2023
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene TherapiesLogan Thrasher Collins, Selvarangan Ponnazhagan, David T Curiel
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Cancer gene therapy and immunotherapyYosuke Kawakami, Tyler J Curiel, David T Curiel
Pageof 40